株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アルツハイマー病:競合情勢

Alzheimer's Disease: Competitive Landscape to 2026

発行 GlobalData 商品コード 673448
出版日 ページ情報 英文 49 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.65円で換算しております。
Back to Top
アルツハイマー病:競合情勢 Alzheimer's Disease: Competitive Landscape to 2026
出版日: 2018年06月30日 ページ情報: 英文 49 Pages
概要

当レポートでは、アルツハイマー病に関する臨床研究の最新動向について調査し、疾患・治療薬の概要、各地域の治験状況、パイプラインの評価、研究の進捗状況、主要企業の動向などをまとめています。

第1章 序文

  • 目次
  • 略語一覧
  • 関連調査
  • 出版予定の関連調査

第2章 エグゼクティブサマリー

  • 主な調査成果
  • 主なイベント

第3章 イントロダクション

  • レポート範囲
  • 疾病概要と疫学

第4章 パイプライン評価

  • パイプライン概要
  • パイプラインの内訳:地域・国別
  • パイプラインの内訳:分子タイプ・標的別
  • 薬品レビュー
  • 臨床開発中の製品

第5章 治験の評価

  • 臨床試験の概要
  • 治験の主要スポンサー
  • 治験の内訳:地域別
  • 治療分野
  • 患者登録

第6章 商業的評価

  • 主な上市製品
  • 現在活躍中・今後活躍が期待される企業

第7章 競合環境の分析

  • イベント区分
  • 米国
  • EU5カ国
  • 日本
  • 中国

第8章 付録

目次
Product Code: GDHC011CL

Alzheimer's disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline. The degeneration of neurons starts in the brainstem before progressing to the hippocampus, frontal lobe, amygdala, parietal lobe, and temporal lobe. The cause of AD is unknown, but it appears to be multifactorial, with most research aimed at the AB peptides and tau proteins. The irregular clearance and metabolism of these proteins are likely contributors to the presentation of the disease. The risk of developing AD is believed to be determined by a combination of genetic, metabolic, behavioral, and environmental factors.

This report provides an assessment of the pipeline, clinical, and commercial landscape of AD. Overall, GlobalData expects new drug approvals to drive AD market growth over the next decade (2016-2026).

Scope

This report combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. Components of the slide deck include -

  • Pipeline Assessment: regional breakdown, promising late-stage products, early-stage pipeline by molecule type
  • Clinical Trials Assessment: trial breakdown by phase, leading industry and non-industry sponsors, enrollment analytics
  • Commercial Assessment: leading marketed products, current and future players
  • Competitive Landscape Analysis: key market events (2016-2026).

Reasons to buy

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global AD market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global AD market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

1. Preface 2

  • 1.1 Table of Contents 2
  • 1.2 Abbreviations 3
  • 1.3 Related Reports 4
  • 1.4 Upcoming Related Reports 5

2. Executive Summary 6

  • 2.2 Key Findings 7
  • 2.2 Key Events 8

3. Introduction 9

  • 3.1 Report Scope 10
  • 3.2 Disease Overview and Epidemiology 12

4. Pipeline Assessment 15

  • 4.1 Pipeline Overview 16
  • 4.2 Pipeline Breakdown by Region/Country 18
  • 4.3 Pipeline Breakdown by Molecule Type and Target 19
  • 4.4 Drug Review Designations 20
  • 4.5 Products in Clinical Development 21

5. Clinical Trial Assessment 23

  • 5.1 Clinical Trials Overview 24
  • 5.2 Top Sponsors of Clinical Trials in AD 25
  • 5.3 Trial Breakdown by Region 27
  • 5.4 Therapy Area Perspective 28
  • 5.5 Enrollment Analytics 29

6 Commercial Assessment 32

  • 6.1 Leading Marketed Products 33
  • 6.2 Current & Future Players 34

7. Competitive Landscape Analysis (2016-2026) 35

  • 7.1 Events Classification Overview 36
  • 7.2 US 37
  • 7.3 5EU 38
  • 7.4 Japan 39
  • 7.5 China 40

8 Appendix 42

  • 8.1 Sources 43
  • 8.2 Methodology 45
  • 8.3 Key Events Included in the Analysis 46
  • 8.4 About the Authors 47
  • 8.5 About GlobalData 50
  • 8.6 Disclaimer 52
Back to Top